WHO key access antibiotics prices, availability and affordability in private sector pharmacies in Pakistan

Saleem, Zikria; Saeed, Hamid; Akbar, Zunaira; Saeed, Amna; Khalid, Saleha; Farrukh, Laiba; Irfan, Aleena; Anam, Azka; Hassali, Mohamed Azmi; Rasheed, Huma; Babar, Zaheer-Ud-Din

doi:10.1186/s12962-021-00263-x

Cost Effectiveness and Resource Allocation

Table 3 Individual median price ratios (MPRs) for surveyed antibiotics

From: WHO key access antibiotics prices, availability and affordability in private sector pharmacies in Pakistan

Medicine Name	Type	MPR	25%tile	75%tile	Min	Max
Cap. Doxycycline 100 mg J01AA02	OB	4.33	4.33	4.33	3.75	4.34
Cap. Doxycycline 100 mg J01AA02	LPG	2.90	1.70	3.92	1.36	4.94
Cap. Ampicillin 500 mg J01CA01	OB	1.50	1.35	1.50	1.25	1.50
Cap. Ampicillin 500 mg J01CA01	LPG	NA	NA	NA	NA	NA
Cap. Amoxicillin 500 mg J01CA04	OB	2.60	2.60	2.61	2.48	2.61
Cap. Amoxicillin 500 mg J01CA04	LPG	1.87	1.51	2.26	1.06	2.59
Inj. Benzyl penicillin 1MIU J01CE01	OB	NA	NA	NA	NA	NA
Inj. Benzyl penicillin 1MIU J01CE01	LPG	1.79	1.66	1.82	1.28	1.92
Tab. Co-amoxiclav 625 mg J01CR04	OB	1.20	1.19	1.20	1.19	1.20
Tab. Co-amoxiclav 625 mg J01CR04	LPG	1.10	1.08	1.11	0.86	1.17
Inj. Piperacillin + tazobactum 4500 mg J01CR05	OB	2.45	2.45	2.45	2.34	2.45
Inj. Piperacillin + tazobactum 4500 mg J01CR05	LPG	2.07	2.07	2.07	2.34	2.45
Cap. Cefalexin 500 mg J01DB01	OB	1.94	1.92	1.95	1.92	1.99
Cap. Cefalexin 500 mg J01DB01	LPG	1.83	1.69	1.93	1.53	1.95
Inj. Cefotaxime 1 g J01DD01	OB	2.32	2.32	2.32	2.32	2.32
Inj. Cefotaxime 1 g J01DD01	LPG	1.47	0.88	1.96	0.86	2.01
Inj. Ceftriaxone 1 g inj J01DD04	OB	15.31	15.31	15.31	15.31	15.31
Inj. Ceftriaxone 1 g inj J01DD04	LPG	6.38	6.04	6.38	4.78	8.66
Cap. Cefixime 400 mg J01DD08	OB	NA	NA	NA	NA	NA
Cap. Cefixime 400 mg J01DD08	LPG	2.17	2.14	2.47	1.32	2.47
Inj. Meropenem 1 g J01DH02	OB	NA	NA	NA	NA	NA
Inj. Meropenem 1 g J01DH02	LPG	1.44	1.44	1.80	0.73	2.06
Tab. Sulfamethoxazole + trimethoprim 960 mg J01EE01	OB	0.74	0.73	1.48	0.71	1.50
Tab. Sulfamethoxazole + trimethoprim 960 mg J01EE01	LPG	NA	NA	NA	NA	NA
Tab.Clarithromycin 500 mg J01FA09	OB	2.34	2.34	2.34	1.78	2.38
Tab.Clarithromycin 500 mg J01FA09	LPG	1.55	1.27	1.55	1.16	1.58
Tab. Azithromycin 250 mg J01FA10	OB	NA	NA	NA	NA	NA
Tab. Azithromycin 250 mg J01FA10	LPG	1.98	1.70	2.14	1.55	3.29
Tab. Clindamycin 300 mg J01FF01	OB	2.50	2.50	2.54	2.49	3.33
Tab. Clindamycin 300 mg J01FF01	LPG	NA	NA	NA	NA	NA
Inj. Gentamicin 40 mg/ml J01GB03	OB	NA	NA	NA	NA	NA
Inj. Gentamicin 40 mg/ml J01GB03	LPG	3.04	3.03	3.05	3.02	3.07
Inj. Amikacin 50 mg/ml J01GB06	OB	NA	NA	NA	NA	NA
Inj. Amikacin 50 mg/ml J01GB06	LPG	1.88	1.87	1.88	1.87	12.44
Tab. Ciprofloxacin 500 mg J01MA02	OB	12.42	12.34	12.45	12.15	12.45
Tab. Ciprofloxacin 500 mg J01MA02	LPG	5.77	5.23	6.81	2.53	6.96
Inj. Vancomycin 500 mg J01XA01	OB	4.06	4.06	4.42	3.33	5.37
Inj. Vancomycin 500 mg J01XA01	LPG	3.73	3.54	4.06	3.42	4.06
Tab. Metronidazole 400 J01XD01	OB	1.21	1.21	1.23	1.15	1.41
Tab. Metronidazole 400 J01XD01	LPG	1.16	1.15	1.18	1.15	1.20

Cap Capsule, Tab Tablet, Inj Injection, MPR Median Price Ratio

Back to article page

ISSN: 1478-7547

Contact us

General enquiries: journalsubmissions@springernature.com